title: Clinical significance of soluble interleukin 2 receptor for monitoring the diseases associated with activated lymphocytes and viral infections.
authors.affiliation: Diagnostic R&D Department, Yamanouchi Pharmaceutical Co., Ltd., Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Obara
authors.forename: M A
authors.initials: MA
authors.lastname: Vodian
authors.forename: P C
authors.initials: PC
authors.lastname: Kung
mesh_terms: D001171:Arthritis, Juvenile / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D006084:Graft Rejection; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000378:metabolism*; D012995:Solubility; D014777:Virus Diseases / Q000276:immunology*
chemical_list: D015415:Biomarkers; D015375:Receptors, Interleukin-2